Partnering to Improve Health for All

As we work to advance progress against the United Nations’ Sustainable Development Goal 3 (SDG3) — which includes a call for universal health coverage (UHC) by 2030 — we know that we must work differently to do more in the face of today’s unprecedented challenges to ensure all people have access to the quality health services they need.

“To make the shared vision of SDG3 a reality will require innovative partnerships, bold investments, and the capability to scale successes,” said Caroline Roan, Vice President, Global Health & Patient Access.

For more than 160 years, Pfizer has made significant, far-reaching contributions to improving health around the world, helping to increase access to life-saving products and strengthen health systems to deliver for the most vulnerable people. But given the complexity of the global health landscape, there is no such thing as status quo. We must continually evolve our approach, finding new solutions that are not only transformative but also sustainable.

In order to promote health and well-being for all, we leverage the full extent of our resources – from our medicines and vaccines to our financial investments and our colleagues’ expertise – in areas and communities where we can have the greatest impact. Through innovative partnerships and programs, Pfizer and its partners are helping to drive progress in bold ways that support local communities by strengthening systems and increasing access to care:

Through the Pfizer Foundation* Healthy Families, Healthy Futures program, we have supported more than 121,000 women in five African countries through programs that integrate the delivery of childhood immunizations and family planning services, breaking down barriers to access and increasing efficiencies to maximize impact.
Similarly, through our Healthy Communities initiative, we’ve partnered with Population Services International to help improve the diagnosis and treatment of hypertension in Myanmar and Vietnam, where it affects one-quarter of adults and is a leading cause of morbidity. To date, the program has trained 485 providers, screened more than 313,000 patients, diagnosed 54,000 patients and treated more than 40,000 patients.
In partnership with the International Trachoma Initiative, we’ve donated more than 800 million doses of antibiotics to 40 countries to fight trachoma, a debilitating disease that is the leading infectious cause of blindness worldwide and results in up to $8 billion in lost productivity each year.
As a partner of Gavi, the vaccines Alliance, we’ve helped to make pneumococcal conjugate vaccines available in some of the world’s poorest countries, which protects more than 29 million babies from pneumonia in Gavi-supported countries each year.
Through Pfizer RxPathways®, we have helped more than 679,000 patients receive over 9 million Pfizer prescriptions for free or at a savings in the last five years.
Through Accelerate2030, a nine-month capacity-building program with a mission to support and scale social ventures that contribute to the SDGs, we’ve helped to reach 2 million people with 80+ impact-driven ventures.
Since 2003, roughly 500 Pfizer colleagues have contributed their expertise to build capacity and strengthen healthcare delivery in low- and middle-income countries, working with 73 partner organizations in 50 nations through our Global Health Fellows and Global Health Teams.

There is no one path to universal health coverage. We’re proud of the efforts of our colleagues, partners, and peers to improve global health and ensure health for all.

Watch the video below to learn more about how we’re committed to creating a healthier world.

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.